InvestorsHub Logo
Followers 35
Posts 1393
Boards Moderated 0
Alias Born 09/09/2009

Re: None

Thursday, 10/01/2015 12:51:40 PM

Thursday, October 01, 2015 12:51:40 PM

Post# of 144815
We are initiating coverage on PharmaCyte Biotech (PMCB) as the stock is 10 cents away from crossing above its $.1838 SqueezeTrigger Price. PharmaCyte's technology is called Cell-in-a-Box®. In simplest terms, PharmaCyte Biotech has developed Cell-in-a-Box® as a means of encapsulating and implanting living cells into a patient's body where they can drive a specific therapeutic effect. In the case of PharmaCyte's pancreatic cancer therapy, these encapsulations (about the size of the head of a pin) contain about 10,000 live cells each that produce an enzyme that activates the cancer-fighting drug ifosfamide.

BUYINS.NET


GO LONG NOW...we could gain that in a day or 2 with the right PR...
bull
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News